FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Pfizer Unasyn Recall

Unasyn (ampicillin sodium/sulbacatam) for injection, 1

Pfizer Inc. · New York, NY

Risk level
Class II
Reported by FDA
Jun 17, 2020
Recall ID
D-1306-2020
Check your lot numberHow we source this data

Summary

Pfizer recalled Unasyn starting May 29, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1306-2020 on Jun 17, 2020. Reason: Presence of Particulate Matter: particulate matter identified after reconstitution. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: particulate matter identified after reconstitution.

Product description

Unasyn (ampicillin sodium/sulbacatam) for injection, 1.5 g* per vial, Rx Only, 10 vials/carton, Made in Italy Distributed by Roerig Division of Pfizer Inc. New York, NY 10017 vial NDC 0049-0013-81, carton NDC 0049-0013-83

Lot numbers, UPCs & expiration codes

Lot # 3301612, EXP 02/2022

Where it was sold

Distributed Nationwide in the US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1306-2020
Classification
Class II
Status
Terminated
Recall initiated
May 29, 2020
FDA report date
Jun 17, 2020
Quantity
94320 units
Recall type
Voluntary: Firm initiated
Recalling firm
Pfizer Inc.

Original FDA data

Every field from FDA enforcement report D-1306-2020, exactly as published.

Show all FDA fields
City
New York
State
NY
Status
Terminated
Country
United States
Event ID
85754
Address
235 E 42nd St
Code information
Lot # 3301612, EXP 02/2022
Postal code
10017-5703
Report date
Jun 17, 2020
Product type
Drugs
Recall number
D-1306-2020
Classification
Class II
Recalling firm
Pfizer Inc.
Product quantity
94320 units
Termination date
Jan 13, 2022
Reason for recall
Presence of Particulate Matter: particulate matter identified after reconstitution.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Unasyn (ampicillin sodium/sulbacatam) for injection, 1.5 g* per vial, Rx Only, 10 vials/carton, Made in Italy Distributed by Roerig Division of Pfizer Inc. New York, NY 10017 vial NDC 0049-0013-81, carton NDC 0049-0013-83
Distribution pattern
Distributed Nationwide in the US
Recall initiation date
May 29, 2020
Initial firm notification
Letter
Center classification date
Jun 12, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1306-2020, published Jun 17, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls